Relapsing Syndrome of Inappropriate Antidiuretic Hormone Production Responding to Tolvaptan Treatment in a Patient With a Micronodular Formation of the Posterior Pituitary Gland.
Journal
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
ISSN: 1439-3646
Titre abrégé: Exp Clin Endocrinol Diabetes
Pays: Germany
ID NLM: 9505926
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
medline:
11
9
2023
pubmed:
27
6
2023
entrez:
26
6
2023
Statut:
ppublish
Résumé
The syndrome of inappropriate ADH-secretion (SIADH) is a common cause of low sodium levels with diverse aetiology. Here, we report a case of a 41 years old male patient diagnosed with SIADH and a good response to Tolvaptan therapy. Of interest, as a potential unique cause, magnetic resonance imaging revealed a micronodular structure in the posterior pituitary, while no other common cause of SIADH could be identified. Hence, to the best of our knowledge, this is the first case of a Tolvaptan-responsive SIADH associated with a pituitary micronodular structure.
Identifiants
pubmed: 37364592
doi: 10.1055/a-2093-1002
pmc: PMC10581092
doi:
Substances chimiques
Tolvaptan
21G72T1950
Antidiuretic Hormone Receptor Antagonists
0
Benzazepines
0
Vasopressins
11000-17-2
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
472-475Informations de copyright
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
Neuroendocrinology. 2006;83(2):117-22
pubmed: 16864995
Ther Clin Risk Manag. 2020 Jul 24;16:663-672
pubmed: 32801723
Rev Endocr Metab Disord. 2019 Sep;20(3):283-294
pubmed: 31656992
Dtsch Arztebl Int. 2018 May 4;115(18):309-315
pubmed: 29807559
Clin Endocrinol (Oxf). 2019 Jul;91(1):22-32
pubmed: 31004513
Curr Pharm Des. 2012;18(30):4714-24
pubmed: 22794200
N Engl J Med. 2017 Oct 5;377(14):1368-1377
pubmed: 28976856
N Engl J Med. 2007 May 17;356(20):2064-72
pubmed: 17507705
Case Rep Endocrinol. 2019 Apr 2;2019:7592648
pubmed: 31061738
Am J Physiol Regul Integr Comp Physiol. 2018 Apr 1;314(4):R623-R628
pubmed: 29364701
Medicines (Basel). 2021 Jul 19;8(7):
pubmed: 34357155
Prz Gastroenterol. 2016;11(2):78-89
pubmed: 27350834
Endocr J. 2004 Aug;51(4):435-8
pubmed: 15351800
Pituitary. 2022 Feb;25(1):201-209
pubmed: 34580820
Neuropeptides. 2021 Oct;89:102167
pubmed: 34175655